Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...
Calling scientific and technological innovation the ‘main battlefield of international strategic competition’, agriculture ...
Purple Biotech has entered a Phase II trial with its small molecule drug, NT219, focusing on patients with ...
We recently published a list of 10 Low Price High Volume Stocks to Buy Now. In this article, we are going to take a look at ...
Biotech continues to make good progress in 2025 with key regulatory and clinical advancements, reinforcing pelareorep’s ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, continues to make good progress in 2025 with key regulatory and ...
Jill Collins, CEO, Chief Strategy Officer, Audacity Health.
Union minister Jitendra Singh on Monday said India is being recognized as global leader in space technology, biotechnology and preventive healthcare, crediting the remarkable achievements to the ...
Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...
Using a series of more than 1,000 X-ray snapshots of the shapeshifting of enzymes in action, researchers at Stanford ...
After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results